Sort by
Items per page

Send to

Choose Destination

Best matches for xanthohumol and cancer:

Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro. Sławińska-Brych A et al. Chem Biol Interact. (2015)

Xanthohumol induces apoptosis and S phase cell cycle arrest in A549 non-small cell lung cancer cells. Yong WK et al. Pharmacogn Mag. (2015)

Xanthohumol induces growth inhibition and apoptosis in ca ski human cervical cancer cells. Yong WK et al. Evid Based Complement Alternat Med. (2015)

Search results

Items: 1 to 20 of 141


Xanthohumol attenuates cisplatin-induced nephrotoxicity through inhibiting NF-κB and activating Nrf2 signaling pathways.

Li F, Yao Y, Huang H, Hao H, Ying M.

Int Immunopharmacol. 2018 Jun 12;61:277-282. doi: 10.1016/j.intimp.2018.05.017. [Epub ahead of print]


Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Humulus lupulus L.).

Jiang CH, Sun TL, Xiang DX, Wei SS, Li WQ.

Front Pharmacol. 2018 May 22;9:530. doi: 10.3389/fphar.2018.00530. eCollection 2018. Review.


Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.

Yang J, Li B, He QY.

Cell Death Dis. 2018 May 21;9(6):580. doi: 10.1038/s41419-018-0661-3.


miR-4725-3p targeting Stim1 signaling is involved in xanthohumol inhibition of glioma cell invasion.

Ho KH, Chang CK, Chen PH, Wang YJ, Chang WC, Chen KC.

J Neurochem. 2018 May 10. doi: 10.1111/jnc.14459. [Epub ahead of print]


Synthesis and Antiproliferative Activity of Minor Hops Prenylflavonoids and New Insights on Prenyl Group Cyclization.

Popłoński J, Turlej E, Sordon S, Tronina T, Bartmańska A, Wietrzyk J, Huszcza E.

Molecules. 2018 Mar 28;23(4). pii: E776. doi: 10.3390/molecules23040776.


The hop-derived compounds xanthohumol, isoxanthohumol and 8-prenylnaringenin are tight-binding inhibitors of human aldo-keto reductases 1B1 and 1B10.

Seliger JM, Misuri L, Maser E, Hintzpeter J.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):607-614. doi: 10.1080/14756366.2018.1437728.


Inhibition of breast cancer cell survival by Xanthohumol via modulation of the Notch signaling pathway in vivo and in vitro.

Sun Z, Zhou C, Liu F, Zhang W, Chen J, Pan Y, Ma L, Liu Q, Du Y, Yang J, Wang Q.

Oncol Lett. 2018 Jan;15(1):908-916. doi: 10.3892/ol.2017.7434. Epub 2017 Nov 17.


Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy.

Rajagopal C, Lankadasari MB, Aranjani JM, Harikumar KB.

Pharmacol Res. 2018 Apr;130:273-291. doi: 10.1016/j.phrs.2017.12.034. Epub 2018 Jan 4. Review.


Chalcones as putative hepatoprotective agents: Preclinical evidence and molecular mechanisms.

Karimi-Sales E, Mohaddes G, Alipour MR.

Pharmacol Res. 2018 Mar;129:177-187. doi: 10.1016/j.phrs.2017.11.022. Epub 2017 Nov 23. Review.


Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma.

Walden D, Kunnimalaiyaan S, Sokolowski K, Clark TG, Kunnimalaiyaan M.

Oncotarget. 2017 Sep 30;8(50):88069-88078. doi: 10.18632/oncotarget.21422. eCollection 2017 Oct 20.


Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model.

Zhang W, Pan Y, Gou P, Zhou C, Ma L, Liu Q, Du Y, Yang J, Wang Q.

Oncol Rep. 2018 Jan;39(1):280-288. doi: 10.3892/or.2017.6094. Epub 2017 Nov 13.


Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer.

Saito K, Matsuo Y, Imafuji H, Okubo T, Maeda Y, Sato T, Shamoto T, Tsuboi K, Morimoto M, Takahashi H, Ishiguro H, Takiguchi S.

Cancer Sci. 2018 Jan;109(1):132-140. doi: 10.1111/cas.13441. Epub 2017 Dec 3.


Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues.

Nuti E, Bassani B, Camodeca C, Rosalia L, Cantelmo A, Gallo C, Baci D, Bruno A, Orlandini E, Nencetti S, Noonan DM, Albini A, Rossello A.

Eur J Med Chem. 2017 Sep 29;138:890-899. doi: 10.1016/j.ejmech.2017.07.024. Epub 2017 Jul 17.


In Vitro Effect of 8-Prenylnaringenin and Naringenin on Fibroblasts and Glioblastoma Cells-Cellular Accumulation and Cytotoxicity.

Stompor M, Uram Ł, Podgórski R.

Molecules. 2017 Jun 30;22(7). pii: E1092. doi: 10.3390/molecules22071092.


Comprehensive two-dimensional PC-3 prostate cancer cell membrane chromatography for screening anti-tumor components from Radix Sophorae flavescentis.

Wang Q, Xu J, Li X, Zhang D, Han Y, Zhang X.

J Sep Sci. 2017 Jul;40(13):2688-2693. doi: 10.1002/jssc.201700208.


Xanthohumol induces paraptosis of leukemia cells through p38 mitogen activated protein kinase signaling pathway.

Mi X, Wang C, Sun C, Chen X, Huo X, Zhang Y, Li G, Xu B, Zhang J, Xie J, Wang Z, Li J.

Oncotarget. 2017 May 9;8(19):31297-31304. doi: 10.18632/oncotarget.16185.


In-vitro analysis of selective nutraceuticals binding to human transcription factors through computer aided molecular docking predictions.

Teimouri M, Junaid M, Saleem S, Khan A, Ali A.

Bioinformation. 2016 Oct 17;12(7):354-358. doi: 10.6026/97320630012354. eCollection 2016.


Xanthohumol isolated from Humulus lupulus prevents thrombosis without increased bleeding risk by inhibiting platelet activation and mtDNA release.

Xin G, Wei Z, Ji C, Zheng H, Gu J, Ma L, Huang W, Morris-Natschke SL, Yeh JL, Zhang R, Qin C, Wen L, Xing Z, Cao Y, Xia Q, Li K, Niu H, Lee KH, Huang W.

Free Radic Biol Med. 2017 Jul;108:247-257. doi: 10.1016/j.freeradbiomed.2017.02.018. Epub 2017 Feb 8.


Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor.

Shikata Y, Yoshimaru T, Komatsu M, Katoh H, Sato R, Kanagaki S, Okazaki Y, Toyokuni S, Tashiro E, Ishikawa S, Katagiri T, Imoto M.

Cancer Sci. 2017 Apr;108(4):785-794. doi: 10.1111/cas.13175. Epub 2017 Apr 20.


Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells.

Liu M, Yin H, Qian X, Dong J, Qian Z, Miao J.

Molecules. 2016 Dec 28;22(1). pii: E36. doi: 10.3390/molecules22010036.

Supplemental Content

Loading ...
Support Center